Drug Formulation Challenge 4

Injectable Formulation Developed for a Low Solubility Compound at a High Dose

 

Our client had a poorly soluble, non-ionizable compound and required a high dose injectable formulation for animal studies.


Velesco solution:

  • Regular solvent mixtures were unable to achieve the required dose, but the precipitation characteristics suggested nucleation inhibitors might work.
  • A successful non-toxic drug formulation containing anti-nucleation polymers was developed.

Back to drug formulation development case studies

News and Events

 

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.

 

                                                                              Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.                          Read the press release here.

  

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing

  

2 new job postings! Careers 

  

Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.

  

Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100

 

734-274-9877